NCT07816523Active, not recruiting
Intergrated Service Delivery for Lung Health Conditions
Advancing Lung Health in Zambia Through Increasing Access to Integrated and Comprehensive Screening, Diagnosis and Management of TB and Other Chronic Respiratory Diseases at Community and Primary Care Levels
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
The Advancing Lung Health in Zambia project aims to improve access to integrated screening, diagnosis, and management of tuberculosis (TB) and other priority respiratory diseases at community and primary healthcare levels. The project recognizes that many lung diseases present with similar symptoms, such as persistent cough, shortness of breath, chest pain, and difficulty breathing. Because of this overlap, focusing on a single disease can result in missed or delayed diagnoses for patients with other serious respiratory conditions. Guided by the World Health Organization's Practical Approach to Lung Health (PAL), the project promotes integrated assessment of people presenting with respiratory symptoms. The main conditions of interest include TB, post-TB lung disease (PTLD), pneumonia, silicosis, and chronic obstructive pulmonary disease (COPD). This approach ensures that patients receive comprehensive evaluation and appropriate care regardless of the underlying cause of their symptoms. A key feature of the project is the use of AI-enabled digital chest X-ray technology to support early and accurate detection of lung abnormalities. The technology assists healthcare workers in identifying signs of TB and other respiratory diseases, improving clinical decision-making and timely referral for further diagnosis and treatment. The project also strengthens healthcare worker capacity, expands access to diagnostic services, enhances community awareness, and improves referral and follow-up systems. In addition, it seeks to generate evidence on the burden and patterns of non-TB respiratory diseases in Zambia while documenting good practices and lessons learned from integrated lung health screening. The evidence generated will help inform policy, strengthen primary healthcare services, and support the scale-up of integrated lung health approaches, ultimately improving respiratory health outcomes and access to quality care across Zambia.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 20300 (estimated)
- First submitted
- 17 Aug 2026
- Start date
- 3 Mar 2025
- Primary completion date
- Sept 2026
- Lead sponsor
- Centre for Infectious Disease Research in Zambia
- Diseases
- Tuberculosis, COPD
- NCT number
- NCT07816523
What you commit to
- Study type: Observational
- Planned participants: 20300
- From 3 Mar 2025 to the primary completion date, Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Not a presumptive TB patient by chest Xray or clinical symptoms.
- Post-TB Lung disease sub-study
Age
- Aged less than 18
- Aged less than 18
Other
- For the nested sub-studies, the following are the exclusion criteria
- Evaluation of the sound AI screening tool:
- Does not provide written informed consent
- Does not provide written informed consent
- Clinically diagnosed TB.
Who the study is looking for
- For the intergrated service delivery screening for lung health conditions:
- Presumptive TB patients (individuals with symptoms or findings suggestive of TB).
- Household contacts of confirmed TB patients.
- Newly diagnosed people living with HIV (PLHIV).
- People with respiratory conditions.
- Workers from dust-generating industries within the district, such as mining and related
- Persons who have a history of cigarrete smoking
- Any person who feels at risk of lung health conditions, with or without symptoms.
- For the nested sub-studies the following are the inclusion criteria:
- Evaluation of the sound AI screening tool:
- Presumptive TB patient either by symptoms or determined by chest Xray
- Aged 18 and above
- Provides written informed consent to participate in the study
- Post-TB Lung disease sub-study
- Persons diagnosed with bacteriologically confirmed TB with WHO Recommended Rapid Molecular diagnostic tests or sputum smear
- Aged 18 and above
- Provides written informed consent to participate in the sub-study
Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kafue District Hospital, Nangongwe Health Centre, Railway Clinic, Kafue Estates Clinic, and Chisankane Rural Health Centre Coordinator of this site? Confirm its status | Kafue | Zambia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.